KD Logo

Neumora Therapeutics Inc. [NMRA] Records 50-Day SMA of $14.16

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Neumora Therapeutics Inc. shares valued at $40,217 were purchased by Burow Kristina on Nov 14 ’23. At $11.98 per share, Burow Kristina acquired 3,357 shares. The insider’s holdings grew to 4,131,207 shares worth approximately $37.59 million following the completion of this transaction.

Also, ARCH Venture Partners XII, LLC purchased 3,357 shares, netting a total of over 40,217 in proceeds. Following the buying of shares at $11.98 each, the insider now holds 4,131,207 shares.

Before that, ARCH Venture Partners XII, LLC had added 31,653 shares to its account. In a trade valued at $371,923, the 10% Owner bought Neumora Therapeutics Inc. shares for $11.75 each. Upon closing the transaction, the insider’s holdings increased to 31,653 shares, worth approximately $37.56 million.

As published in their initiating research note from Deutsche Bank on December 12, 2023, Neumora Therapeutics Inc. [NMRA] has been a Hold and the price target has been revised to $13. Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in early October. As of October 10, 2023, Stifel has initiated its “Buy” rating for NMRA. Earlier on October 10, 2023, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for NMRA stock.

Analyzing NMRA Stock Performance

During the last five days, there has been a drop of approximately -5.11%. Over the course of the year, Neumora Therapeutics Inc. shares have dropped approximately -46.63%. Nevertheless, trading volume fell to 0.5 million shares from 0.41 million shares the previous day.

Support And Resistance Levels for Neumora Therapeutics Inc. (NMRA)

According to the 24-hour chart, there is a support level at 8.84, which, if violated, would cause prices to drop to 8.57. In the upper region, resistance lies at 9.43. The next price resistance is at 9.75. RSI (Relative Strength Index) is 26.34 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.00, which suggests the price will decrease in the coming days. Percent R is at 94.56%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular

[the_ad id="945"]